CD30+ lymphomatoid drug reactions

American Journal of Dermatopathology

Volumn 35, Issue 3, 2013, Pages 343-350

  Pulitzer, Melissa P ^a   Nolan, Katherine A ^b   Oshman, Robin G ^b   Phelps, Robert G ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

CD30 Antigen; Drug Eruptions; Lymphoproliferative Disorder; Pseudolymphoma

Indexed keywords

AMLODIPINE; ATENOLOL; BECLOMETASONE DIPROPIONATE; CARBAMAZEPINE; CD30 ANTIGEN; CEFEPIME; CLONAZEPAM; DOCUSATE SODIUM; ENALAPRIL; FLUOXETINE; FUROSEMIDE; GABAPENTIN; GLIBENCLAMIDE; LEVOFLOXACIN; METOPROLOL; MONTELUKAST; OLANZAPINE; PREDNISONE; SALBUTAMOL; SALMETEROL; SERTRALINE; SPIRONOLACTONE; TACROLIMUS; TRAZODONE; WARFARIN;

ADULT; AGED; ALLERGY; ARTICLE; CASE REPORT; DERMATITIS; DESQUAMATION; DRUG MECHANISM; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; LYMPHOCYTE; MALE; MEDICAL HISTORY; PAPULE; PRIORITY JOURNAL; PSEUDOLYMPHOMA;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; AMINES; AMLODIPINE; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; ANTIGENS, CD30; BIOLOGICAL MARKERS; BIOPSY; CALCIUM CHANNEL BLOCKERS; CYCLOHEXANECARBOXYLIC ACIDS; DRUG ERUPTIONS; ERYTHEMA; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; MALE; METOPROLOL; MIDDLE AGED; OFLOXACIN; PREDICTIVE VALUE OF TESTS; PSEUDOLYMPHOMA; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SKIN;

EID: 84876722191     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31826bc1e5     Document Type: Article

References (31)

1. Bigby M, Jick S, Jick H, et al. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA. 1986;256: 3358-3363
2. Kabashima R, Orimo H, Hino R, et al. CD30-positive T-cell pseudolymphoma induced by amlodipine. J Eur Acad Dermatol Venereol. 2008;22: 1522-1524
3. Nathan DL, Belsito DV. Carbamazepine-induced pseudolymphoma with CD-30 positive cells. J Am Acad Dermatol. 1998;38:806-809
4. Sawada Y, Yoshiki R, Kawakami C, et al. Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption. Acta Derm Venereol. 2010;90:521-522
5. Magro CM, Crowson AN, Kovatich AJ, et al. Drug-induced reversible lymphoid dyscrasia: A clonal lymphomatoid dermatitis of memory and activated T cells. Hum Pathol. 2003;34:119-129
6. Schwab U, Stein H, Gerdes J, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature. 1982;299:65-67
7. Kempf W. CD30+ lymphoproliferative disorders: Histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol. 2006; 33(suppl 1):58-70
8. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785
9. Willemze R, Meijer CJ. Primary cutaneous CD30-positive lymphoproliferative disorders. Hematol Oncol Clin North Am. 2003;17:1319-1332, vii-viii
10. Barbosa HS, Bittencourt AL, Barreto de Araujo I, et al. Adult T-cell leukemia/lymphoma in northeastern Brazil: A clinical, histopathologic, and molecular study. J Acquir Immune Defic Syndr. 1999;21:65-71
11. Carrozza PM, Kempf W, Kazakov DV, et al. A case of Sezary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma. Br J Dermatol. 2002;147:582-586
12. Berti E, Tomasini D, Vermeer MH, et al. Primary cutaneous CD8- positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155:483-492
13. Weenig RH, Ng CS, Perniciaro C. Subcutaneous panniculitis-like T-cell lymphoma: An elusive case presenting as lipomembranous panniculitis and a review of 72 cases in the literature. Am J Dermatopathol. 2001;23: 206-215
14. Cepeda LT, Pieretti M, Chapman SF, et al. CD30-positive atypical lymphoid cells in common non-neoplastic cutaneous infiltrates rich in neutrophils and eosinophils. Am J Surg Pathol. 2003;27:912-918
15. Cesinaro AM, Maiorana A. Verruca vulgaris with CD30-positive lymphoid infiltrate: A case report. Am J Dermatopathol. 2002;24:260-263
16. Rose C, Starostik P, Brocker EB. Infection with parapoxvirus induces CD30-positive cutaneous infiltrates in humans. J Cutan Pathol. 1999;26: 520-522
17. de Diego J, Berridi D, Saracibar N, et al. Cutaneous pseudolymphoma in association with molluscum contagiosum. Am J Dermatopathol. 1998; 20:518-521
18. Resnik KS, DiLeonardo M. Herpes incognito. Am J Dermatopathol. 2000;22:144-150
19. McCalmont TH, LeBoit PE. A lymphomatoid papule, but not lymphomatoid papulosis! Am J Dermatopathol. 2000;22:188-190
20. Saeed SA, Bazza M, Zaman M, et al. Cefuroxime induced lymphomatoid hypersensitivity reaction. Postgrad Med J. 2000;76:577-579
21. Magro CM, Crowson AN. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: A hypothesis. Hum Pathol. 1996;27:125-132
22. Folster-Holst R, Henseler T, Wehde J, et al. Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis. Acta Derm Venereol. 2002;82:245-248
23. Tarkowski M. Expression and a role of CD30 in regulation of T-cell activity. Curr Opin Hematol. 2003;10:267-271
24. Diamantidis MD, Papadopoulos A, Kaiafa G, et al. Differential diagnosis and treatment of primary, cutaneous, anaplastic large cell lymphoma: Not always an easy task. Int J Hematol. 2009;90:226-229
25. deShazo RD, Kemp SF. Allergic reactions to drugs and biologic agents. JAMA. 1997;278:1895-1906
26. Harada K, Tsuneyama K, Hiramatsu K, et al. Significance of CD30- positive lymphocytes in livers in primary biliary cirrhosis. J Gastroenterol Hepatol. 1999;14:1197-1202
27. Briones J, Novelli S, Sierra J. T-cell costimulatory molecules in acutegraft- versus host disease: Therapeutic implications. Bone Marrow Res. 2011;2011:976793
28. Remes ST, Delezuch W, Pulkki K, et al. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyperresponsiveness at school age. Acta Paediatr. 2011;100:e106-e111
29. Kim KJ, Lee MW, Choi JH, et al. CD30-positive T-cell-rich pseudolymphoma induced by gold acupuncture. Br J Dermatol. 2002;146:882-884
30. Marucci G, Sgarbanti E, Maestri A, et al. Gemcitabine-associated CD8+CD30+ pseudolymphoma. Br J Dermatol. 2001;145:650-652
31. Fukamachi S, Sugita K, Sawada Y, et al. Drug-induced CD30+ T cell pseudolymphoma. Eur J Dermatol. 2009;19:292-294